Women Diagnosed with Early Breast Cancer Since 2000 Have About a Fifth Lower Rate of Distant Recurrence Than Those Diagnosed in the 1990s By Ogkologos - October 24, 2024 707 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a pooled analysis of randomised controlled trial data Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Pembrolizumab with Enfortumab Vedotin-ejfv for Muscle Invasive Bladder Cancer Postneoadjuvant Trastuzumab Deruxtecan Results in Higher Likelihood of iDFS Among Patients with HER2-positive EBC with Residual Invasive Disease After Neoadjuvant Treatment Adding Epcoritamab to Lenalidomide and Rituximab Results in Higher Response Rate and Longer PFS in Patients with Relapsed or Refractory Follicular Lymphoma MOST POPULAR A Diagnosis of Advanced Lung Cancer Is Not a Death Sentence November 19, 2020 What could DeepMind ‘solving’ the protein folding problem mean for cancer... December 23, 2020 Expressive Writing, What is It? May 12, 2021 Shaping Cancer Care in Asia: ESMO Brings Research and Patient Voices... November 28, 2025 Load more HOT NEWS FDA Grants Accelerated Approval to Mirvetuximab Soravtansine-gynx for FRα-Positive, Platinum-Resistant Epithelial... Data Collection Analysis Demonstrates Changes in Lung Cancer Management Throughout the... EMA Recommends Granting a Marketing Authorisation for Pomalidomide Viatris Withdrawal of Application to Change the Marketing Authorisation for Atezolizumab
